Tag Archives: Treatment

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis

FDA Approves Rinvoq (upadacitinib), an Oral JAK Inhibitor for the Treatment of Moderate to Severe Rheumatoid Arthritis Print this page NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), a 15 mg, once-daily oral… Read More »

Antidepressants Reduce Risk of Depression During Pregnancy, Individualized Treatment Essential

For women with histories of major depression, choosing whether to maintain or to discontinue treatment with an antidepressant during pregnancy is often challenging.  This is a process which requires careful and thoughtful consideration, weighing the risk of adverse outcomes associated with exposure to a particular antidepressant against the risk of recurrent illness in the setting… Read More »

What is Duloxetine? Dosage, Side Effects and Best Treatment

What Is Duloxetine? Dosage, Side Effects And Best Treatment Home Wellness What is Duloxetine? Dosage, Side Effects and Best Treatment Duloxetine hydrochloride is indicated for the treatment of depression. Duloxetine dosage is effective in maintaining clinical improvement during continuous treatment for up to six months in patients who have responded to the initial treatment. Duloxetine… Read More »

FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC

Print this page KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for Keytruda, Merck’s anti-PD-1 therapy, as monotherapy for the first-line treatment of patients with stage III non-small cell lung cancer (NSCLC) who are not… Read More »